abstract |
The invention concerns the use of a compound of formula (I) such as defined in Claim 1, for preparing a medicine for treating or preventing conditions corresponding to muscular degeneration of skeletal muscles, such as muscular myopathies of genetic origin, and in particular Duchenne's myopathy, or cachexias. |